Tirzepatide Tirzepatide developed by Eli Lilly is marketed as Mounjaro for treating type 2 diabetes and as Zepbound for chronic weight management
How FDA Regulatory Actions Shape the Compounding Landscape The FDA has issued warning letters and enforcement actions against telehealth platforms and compounding operations that operated without proper oversight, did not verify prescriptions rigorously, or made unsubstantiated claims about medication potency
Intrinsic factor binds to vitamin B12, allowing it to enter the bloodstream
En Espaa, la prevalencia de diabetes se sita en torno al 14%, lo que implica que ms de 4,5 millones de espaoles padecen DM22
It remains unclear whether routine genetic testing for these polymorphisms is necessary or whether current treatment regimens should be adjusted accordingly
It should be noted that once weekly exenatide (Bydureon) is no longer available as it was removed from the market due to commercial considerations by the manufacturer